66 biotech companies
GIP Genopole®
After being founded as a not-for-profit association in 1998 under the impetus of the French government, a number of local authorities and the French Muscular Dystrophy Association (Association Française contre les Myopathies, AFM), Genopole® became a Groupement d’Intérêt Public (GIP, a form of public-private joint venture) on March 1, 2002, for a 12-year period.
The GIP provides an appropriate legal status for attracting and managing resources and funding contributed by both the public and private sectors, whilst maintaining Genopole®’s mission for the common good.
Genopole®’s founding members are:
The French Ministry of Research and Higher Education
Ile-de-France Regional Council
Essonne County Council
The Evry Centre-Essonne Urban Area
The City of Evry
The University of Evry Val-d’Essonne (UEVE)
The French Muscular Dystrophy Association (AFM)
Genopole®’s activities
Genopole® unites the skills, resources and funding needed to achieve its objectives: funding research, promoting therapeutic innovation and transferring technology to industry. At the time of its launch in 1998, Genopole® had a (...)
The Genopole® team
Genopole® is organized into several departments – General Management, Finance & Administration, Research and Teaching, Enterprise, Infrastructure & Technical Facilities, International, Marketing & Public Relations – and has (...)
